The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

1月15日｜美国联邦贸易委员会（FTC）当地时间1月14日发布报告称，美国多家药物福利管理公司通过对治疗癌症和艾滋病的药物收取“巨额加价”，产生超73亿美元收入。FTC点名了CVS健康旗下Caremark、信诺旗下Express ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

FTC点名了CVS健康旗下Caremark、信诺旗下Express Scripts和联合健康集团旗下的Optum，它们管理着美国约80%处方药。 药物福利管理者（PBM）在制药行业中 ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...